The first new drug developed in over a decade for children with attention deficit hyperactivity disorder (ADHD) has been approved by the U.S. Food and Drug Administration. Qelbree, also known as viloxazine, comes in a capsule that is taken daily, and is not a stimulant. This makes it harder to abuse than older ADHD drugs,…  read on >  read on >

TUESDAY, April 6, 2021 (American Heart Association News) — James “Pete” Watt walked into a physical therapy appointment in April 2018 feeling unusually lightheaded and anxious. “I just felt off,” he said. The therapist took his blood pressure reading. It was dangerously high – 200/100. “You’re not going anywhere until someone comes to get you,”…  read on >  read on >

Black Americans are much more likely to report discrimination or unfair judgment when seeking health care than whites or Hispanics, researchers report. “Discrimination and unfair judgment in a health care setting can result in serious ramifications to health and have cumulative adverse effects on people’s lives,” said study author Dulce Gonzalez, a research associate at…  read on >  read on >

Beta-blocker blood pressure medications may increase the risk of heart problems in people with HIV, new research suggests. For the study, the researchers reviewed the medical records of more than 8,000 U.S. veterans with HIV who developed high blood pressure between 2000 and 2018. Of those, around 6,500 had never been diagnosed with heart or…  read on >  read on >